
### [NCIT:C8512](http://purl.obolibrary.org/obo/NCIT_C8512)
**Label:** Malignant Neoplasm with Regional Lymph Node Involvement

**Subclasses:** 

**Class expressions from DL-Learner:**

- [UBERON:0000029](http://purl.obolibrary.org/obo/UBERON_0000029) (lymph node) 62.50%
- [NCIT:C41844](http://purl.obolibrary.org/obo/NCIT_C41844) (Regional Disease) 62.50%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 62.50%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 62.50%
- Thing 51.60%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 40.60%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 40.14%
- [UBERON:0005057](http://purl.obolibrary.org/obo/UBERON_0005057) (immune organ) 37.50%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 33.91%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 21.20%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 14.23%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 14.17%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 14.12%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 14.02%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 14.02%


